An increasing evidence base suggests that low bone mineral density (BMD) and fractures
are associated with cardiovascular disease (CVD). We conducted a systematic review and …

Recent evidence suggests that the traditional syndromes known as renal osteodystrophy,
secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons …

Osteoporosis characterized by low bone mineral density (BMD) as assessed by dual-energy
X-ray absorptiometry (DXA) is common among end-stage renal disease (ESRD) patients …

Abstract Background and Aim: Due to increasing evidence suggesting a link between
hyperphosphatemia and cardiovascular disease (CVD), mediated through vascular …

Objective Chronic kidney disease-mineral bone disorder (CKD-MBD) is a major
complication of end-stage renal disease (ESRD). Reduced bone mineral density (BMD) is …

Background Bone disease with osteoporosis and renal osteodystrophy is common in end
stage renal disease (ESRD) patients and associates with cardiovascular disease (CVD) and …

Recent studies indicate that serum alkaline phosphatase (AlkPhos), a surrogate of high
turnover bone disease, is associated with coronary artery calcification and death risk in …

Although frequently silent, mineral and bone disease (MBD) is one of the most precocious
complication of chronic kidney disease (CKD) and is omnipresent in patients with CKD stage …

Background Alkaline phosphatase (ALP) and bone-specific ALP (BALP) are implicated in
the abnormal skeletal mineralization and accelerated vascular calcification in chronic kidney …

Background: Reduced bone mineral density (BMD) is common in end-stage renal disease
(ESRD) patients and predicts outcomes. The chronic kidney disease–mineral bone disorder …